Cadisegliatin and its Impurities

Cadisegliatin is an oral glucokinase activator investigated for the treatment of type 2 diabetes by improving glucose sensing and enhancing insulin secretion and glycemic control. Reference standards of Cadisegliatin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.